BioSpace News Archive

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the U.S. Food and Drug Administration has accepted the Company’s plan to address the FDA’s concerns that resulted in a Clinical Hold of the HEMO-CAR-T Investigational New Drug application.

Medivir AB announces that the company will present at the Pareto Securities Healthcare Conference.

Nona Biosciences announced an agreement with BeiGene, Ltd. to expand the companies’ discovery strategic collaboration leveraging Nona’s proprietary Harbour Mice® platform.

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of those targets from the Science Based Targets initiative.

PathMaker Neurosystems Inc. announced the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis.

Bionomics Limited announced an update on the company’s α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator collaboration with MSD.

Ocean Biomedical, Inc. will host a live Research & Development update with scientific co-founders, Dr. Jack A. Elias and Dr. Jonathan Kurtis today at 2:00 pm ET on their YouTube channel.

Stryker, one of the world’s leading medical technology companies, unveiled the next-generation of minimally invasive surgical cameras: the 1788 platform.

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21 , 2023.

The CDMO expands its AGCellerate Program to provide Lentiviral vector support for advanced therapies developers